This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Administration of chondroitin sulfate A appears to be effective in preventing heart attacks, according to Lester Morrison, MD, professor and director of the Institute for Arteriosclerosis Research at Loma Linda University School of Medicine.Dr. Morrison reported to the recent American College of Angiology meeting in New York on the results of a double-blind study of 120 patients with a history of myocardial infarction and/or coronary artery disease verified by electrocardiography.Half the patients received chondroitin sulfate A (CSA) in addition to conventional therapy. CSA is a mucopolysaccharide compound.His results were quite dramatic: six "coronary incidents" and five related deaths in the experimental group compared to 36 "coronary incidents" and nine related deaths among the 60 matched control patients.Dr. Morrison added that experimental studies have shown CSA can prevent as well as accelerate regression and healing of coronary and aortic atherosclerosis.The patients had been treated
Internal medicide at large. Arch Intern Med. 1970;126(4):569–580. doi:10.1001/archinte.1970.00310100015002
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: